[1]
|
A. A. Fanarof and R. J. Martin, “Neonatal-Perinatal Medicine Disease of the fetus and infant,” 5th Edition, Mosby, USA, 1992.
|
[2]
|
A. Larsson, “Neonatal Screening for Metabolic, Endocrine, Infectious and Genetic Disorders,” Clinic in Perinatology, 2001, Vol. 28, No. 2, pp. 449-461.
|
[3]
|
WHO Working Group, “Glucose-6-Phosphate Dehydrogenase Deficiency,” Bulletin of the Health Organization, Vol. 67, 1989, pp. 601-611.
|
[4]
|
B. K. Burton, “Inherited metabolic disorders,” In: G. B. Avery, M. A. Fletcher and M. G. MacDonald, Neonatology, Pathophysiology and Management of the Newborn, 5th Edition, Lippincott Williams and Wilkins, USA, 1999, pp. 821-837.
|
[5]
|
M. Kaplan and C. Hammerman, “Glucose-6-Phosphate Dehydrogenase-Deficient Neonates: A Potential Cause for Concern in North America,” Pediatrics, Vol. 106, No. 6, 2000, pp. 1478-1480.
|
[6]
|
M. Kaplan, E. Beutler, H. J. Vreman, C. Hammerman, E. Levy-Lahad, P. Renbaum, et al., “Neonatal Hyperbiliru- Binemia in Glucose-6-Phosphate Dehydrogenase Deficient Heterozygotes,” Pediatrics, Vol. 104, No. 1, Part 1, 1999, pp. 68-74.
|
[7]
|
M. G. McDonald, “Hidden Risks: Early Discharge and Bilirubin Toxicity Due to Glucose-6-Phosphate Dehydrogenase Deficiency,” Pediatrics, Vol. 96, No. 4, Part 1, 1995, pp. 734-738.
|
[8]
|
H. Dahifar, A. Ghorbani and M. Ghods, “Isolated and Non-Isolated Enteric Pathogens in Children with Diarrhea and Related Laboratory Characteristics,” MHIRI, Vol. 22, 2008, pp. 40-46.
|